Evaluation of efficacy of whey protein in contact dermatitis
Not Applicable
- Conditions
- Contact dermatitis.Unspecified contact dermatitis
- Registration Number
- IRCT20190202042587N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 5 years
Contact dermatitis(clinical or with patch test)
Exclusion Criteria
Cows milk allergy
Pregnancy or severe disease as malignancy
Patients who had a new treatment or an increase in the dose within 4 weeks prior to the intervention
Patients treated with immunosuppressive drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduced scores in questionnaire and during periodic examination, which indicate better control of the disease and reduced symptoms. Timepoint: At the beginning of the study, 14 and 28 days after starting the drug. Method of measurement: Questionnaire including EASI (eczema area and severity index) and VAS (visual analog scale) and DLQ index (dermatology life quality index).
- Secondary Outcome Measures
Name Time Method